India to Brazil: Daratumumab Export Trade Route

The India to Brazil Daratumumab corridor is one of India's established pharmaceutical export routes, with 85 shipments documented worth a combined $613.3K USD. The route is dominated by VAMA LIFECARE PRIVATE LIMITED, which alone accounts for roughly 44% of all export value, reflecting the consolidated nature of India's daratumumab manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $7.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with daratumumab's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 12.2%, placing it at rank #3 among India's top daratumumab export destinations globally.

On the import side, key buyers of Indian daratumumab in Brazil include AS PER INVOICE BRAZIL, AS PER INVOICE AS, TO THE CONCERN PERSON and 20 others. AS PER INVOICE BRAZIL is the single largest importer with 12 shipments valued at $93.8K USD.

India's daratumumab exports to Brazil are driven primarily by a handful of large-scale manufacturers. VAMA LIFECARE PRIVATE LIMITED with 29 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VAMA LIFECARE PRIVATE LIMITED, NIVIRA EXPORTS, MELON GLOBALCARE — together account for 90% of total trade value on this route. The average shipment value of $7.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine for human consumptiondaratumumab concentrate for solution forinfusion 400mg/20ml batch no. nds270 and harmless medicine for human consumption daratumumab liquid for injection 1800 mg batch number.: pfs2f13 manuf, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AS PER INVOICE BRAZIL is the largest importer with 12 shipments worth $93.8K USD — representing 15% of all daratumumab imports from India on this route. A total of 23 buyers are active on this corridor.